ROCKVILLE, Md., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that Martin Rosendale, Chief Executive Officer of Cytomedix, will be presenting a corporate update at the 8th Annual BIO Investor Forum on Thursday, October 29th at 2:30 p.m. (Pacific Time) at the Palace Hotel in San Francisco, California.
